Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05525689 · ClinicalTrials.gov registry record · NA

Evaluating Technology Enabled Services in Perinatal Depression

A NA study of Depression, sponsored by Northwestern University.

Completed
Registry status
NA
Development phase
75
Enrollment target
1
Study location

NCT05525689: Completed NA study of Depression, sponsored by Northwestern University.

NCT05525689 is a NA study of Depression that has completed, run by Northwestern University. The registered enrollment target is 75 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05525689, a NA study of Depression, has completed, sponsored by Northwestern University.

COMPLETED
Registry status
NA
Development phase
75 participants
Enrollment target
1
Study location

Study Summary

Investigators are evaluating a Technology Enabled Service (TES) to support the treatment of depression in the context of a collaborative care service in obstetrics clinics.

Primary Outcome

Assessed by Patient Health Questionnaire-9 Scores range from 0-27. Total scores of 5, 10, 15, and 20 represent cutpoints for mild, moderate, moderately severe and severe depression, respectively.

Conditions Studied

Interventions

  • BEHAVIORAL IntelliCare
  • OTHER COMPASS-Care

Study Locations (1)

Illinois

  • Prentice Women's Hospital - Chicago

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2022-06-16
Est. Completion 2024-04-15
Phase NA
Northwestern University

1,209 total trials

What the finished NCT05525689 record still lists

NCT05525689 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 786-participant average among 679 other Depression trials with a reported enrollment target (90% lower).

The record links to 1 condition, with Depression appearing as the primary indexed condition, and to 2 interventions - of which IntelliCare is the first listed.

NCT05525689 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT05525689 about?

NCT05525689 is a clinical study titled "Evaluating Technology Enabled Services in Perinatal Depression". Investigators are evaluating a Technology Enabled Service (TES) to support the treatment of depression in the context of a collaborative care service in obstetrics clinics.

What is the current status of trial NCT05525689?

This trial is currently completed. It is a NA study. The enrollment target is 75 participants. The study started on 2022-06-16. Estimated completion is 2024-04-15.

What conditions does trial NCT05525689 study?

This clinical trial studies the following conditions: Depression.

What interventions are being tested in trial NCT05525689?

The interventions under investigation include: IntelliCare (BEHAVIORAL), COMPASS-Care (OTHER).

Who is sponsoring clinical trial NCT05525689?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05525689 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05525689's enrollment target sits among peer trials

75 387th of 679 higher than 288 of 679 other Depression trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01535430 · 75 participants

    Assessment of Eloquent Function in Brain Tumor Patients

  • NCT01542879 · 75 participants · Phase 1

    Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer

  • NCT02232191 · 75 participants · Phase 2

    Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients

  • NCT02754544 · 75 participants · NA

    Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT06358040 · started 2026-10 · NA

    Opioid Dispenser for Microdiscectomy/Laminectomy

Source: ClinicalTrials.gov NCT05525689, the US trial registry maintained by the National Library of Medicine. NCT05525689 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.